Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes from patients with acute myocardial infarction and modulates the early inflammatory response.
Deng, Ping
Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes from patients with acute myocardial infarction and modulates the early inflammatory response. [electronic resource] - Clinical chemistry Feb 2006 - 300-3 p. digital
Publication Type: Journal Article; Randomized Controlled Trial
0009-9147
10.1373/clinchem.2005.057893 doi
Aged
Anti-Inflammatory Agents, Non-Steroidal--administration & dosage
Atorvastatin
Cyclooxygenase 2--biosynthesis
Female
Heptanoic Acids--administration & dosage
Humans
Leukocytes, Mononuclear--drug effects
Male
Middle Aged
Myocardial Infarction--blood
Protein C--metabolism
Pyrroles--administration & dosage
RNA, Messenger--biosynthesis
Treatment Outcome
Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes from patients with acute myocardial infarction and modulates the early inflammatory response. [electronic resource] - Clinical chemistry Feb 2006 - 300-3 p. digital
Publication Type: Journal Article; Randomized Controlled Trial
0009-9147
10.1373/clinchem.2005.057893 doi
Aged
Anti-Inflammatory Agents, Non-Steroidal--administration & dosage
Atorvastatin
Cyclooxygenase 2--biosynthesis
Female
Heptanoic Acids--administration & dosage
Humans
Leukocytes, Mononuclear--drug effects
Male
Middle Aged
Myocardial Infarction--blood
Protein C--metabolism
Pyrroles--administration & dosage
RNA, Messenger--biosynthesis
Treatment Outcome